Eurocine Vaccines obtains authorization to conduct the next study with Immunose™ FLU
Eurocine Vaccines submitted applications to the Swedish Medical Products Agency, MPA, and to the Ethics Committee in early November. The Company announced today that authorizationsRead…
Eurocine Vaccines Challenges the Flu
“The issued patent in the US earlier this year proves the success of our patent strategy. We now hold at least one granted patent fromRead…
Pulsen på mukosalt
Nyligen hemkommen från årets Influenza Vaccines for the World 2017 * summerar Dr. Anna-Karin Maltais, Forsknings- och utvecklingschef på Eurocine Vaccines, här de viktigaste insikternaRead…
Pulsen på mukosalt
Nyligen hemkommen från årets Influenza Vaccines for the World 2017 * summerar Dr. Anna-Karin Maltais, Forsknings- och utvecklingschef på Eurocine Vaccines, här de viktigaste insikternaRead…
Eurocine Vaccines has received notice of allowance for a US patent application
Eurocine Vaccines has received notice of allowance in the US for one of its patent applications. The patent application, involving the company´s nasal influenza vaccineRead…
Eurocine Vaccines has received notice of allowance for a US patent application
Eurocine Vaccines has received notice of allowance in the US for one of its patent applications. The patent application, involving the company´s nasal influenza vaccineRead…
Eurocine Vaccines strengthens the organization for further development
Eurocine Vaccines strengthens the organization with necessary competence, not only to prepare for further development of its first product, the nasal influenza vaccine candidate Immunose™ FLU,Read…
Eurocine Vaccines strengthens the organization for further development
“In parallel with finalizing the analyses and evaluation of the current study, we now prepare for the next steps of development. Reinforcing the organization withRead…
Eurocine Vaccines expects clinical results June/July 2017
Eurocine Vaccines expects results from the ongoing immunological analyses in June/July 2017. The samples presently being analyzed were collected during the clinical study on theRead…
Eurocine Vaccines expects clinical results June/July 2017
“I am pleased that the progress of the immunological analyses has been somewhat faster than expected”, said CSO Dr. Anna-Karin Maltais.”Read More